≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_BONE_CARTILAGE_EXALLC for full statistics.

Malignant neoplasm of bone and articular cartilage

DOID Endpoint Browser

C3_BONE_CARTILAGE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

307

6. Filter based on genotype QC (FinnGen only)

307

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of bone and articular cartilage based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 307 134 173
Unadjusted period prevalence (%) 0.06 0.05 0.08
Median age at first event (years) 50.08 47.61 52.00

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
289
Matched controls
2887
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
102.1
98.9
105
16
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
120.4
47.5
50
5
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
+∞
47.2
44
*
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
485.1
43.4
42
*
L03AA02
ATC
filgrastim; parenteral
24.1
41.8
60
31
130
Kela drug reimbursment
Malignant tumour
9.8
40.9
90
127
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
37.3
35
*
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
32.9
31
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
11.0
31.2
62
70
N02AA05
ATC
oxycodone; systemic
5.8
31.0
103
253
JN4BD
NOMESCO Finland
Extensive body CT
6.3
29.9
90
194
N03AX16
ATC
pregabalin; oral
4.6
27.1
116
367
NF3AA
NOMESCO Finland
Femur X-ray examination
17.5
26.0
41
27
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
25.4
24
*
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
25.4
24
*
H02AB02
ATC
dexamethasone; systemic
5.8
25.0
78
172
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
17.8
25.0
39
25
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
24.3
23
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
260.6
24.0
24
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.0
24.0
57
86
C90.0
ICD-10 Finland
Multiple myeloma
27.5
23.6
32
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
23.3
182
933
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
71.1
23.2
26
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
23.2
22
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.6
23.0
52
72
WF049
NOMESCO Finland
Radiotherapy of metastasis
11.0
21.7
42
44
R4110
NOMESCO Finland
Physiotherapy
3.7
21.6
125
497
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
21.1
20
*
A04AA01
ATC
ondansetron; systemic, rectal
6.7
20.9
56
100
XW000
NOMESCO Finland
Bone marrow biopsy
9.0
20.8
45
58
B01AB05
ATC
enoxaparin; parenteral
3.5
20.5
131
558
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.3
20.3
145
668
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
19.3
126
540
NG4AA
NOMESCO Finland
Lower leg X-ray examination
11.3
19.0
36
36
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
22.8
19.0
27
13
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
11.6
18.8
35
34
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.9
18.7
89
295
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.7
18.2
55
114
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
17.9
17
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.5
17.9
99
370
XX3DW
NOMESCO Finland
Time consuming IT work
4.8
17.2
61
151
JN4AD
NOMESCO Finland
Body CT examination
5.1
16.5
55
127
GD1AD
NOMESCO Finland
Thorax CT examination
8.2
16.4
37
51
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.8
15.9
28
24
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.5
15.9
35
46
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
15.8
15
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.2
15.7
51
114
WW500
NOMESCO Finland
Blood transfusion
6.9
15.0
38
62
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
14.9
60
168
B01AB10
ATC
tinzaparin; parenteral
5.8
14.8
43
84
9220/3-C41.3
ICD-O-3
Chondrosarcoma, NOS, of rib, sternum, clavicle and associated joints
+∞
14.7
14
*
C41.49
ICD-10 Finland
Malignant tumor of the pelvic bones, sacrum and coccyx other or unspecified histology
+∞
14.7
14
*
C40.02
ICD-10 Finland
Chondrosarcoma of the scapula and long bones of the upper extremity
+∞
14.7
14
*
L03AA13
ATC
pegfilgrastim; parenteral
8.1
14.7
33
45
WX402
NOMESCO Finland
General anaesthesia
3.6
14.6
74
253
WF004
NOMESCO Finland
Palliative radiotherapy
11.8
14.3
26
24
WW300
NOMESCO Finland
Transfer of autologic stem cells
31.8
14.0
18
6
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.1
13.8
45
101
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
78.9
13.7
15
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
+∞
13.6
13
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
27.3
13.5
18
7
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
14.8
13.5
22
16
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
13.0
13.4
23
19
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.6
13.2
39
78
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.7
12.8
37
72
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
33.7
12.7
16
5
9370/3-C41.4
ICD-O-3
Chordoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
12.6
12
*
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
12.6
12
*
L71
ICPC
Malignant neoplasm musculoskeletal
135.6
12.5
13
*
A04AA02
ATC
granisetron; systemic, transdermal
5.0
12.4
41
93
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
39.4
12.3
15
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
10.8
12.2
23
23
153
Kela drug reimbursment
Lenalidomid
28.1
12.2
16
6
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
28.1
12.2
16
6
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
17.3
11.8
18
11
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.9
11.7
29
46
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
8.1
11.7
26
35
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
67.8
11.7
13
*
9101
FHL
Bone biopsy
67.8
11.7
13
*
ZX120
NOMESCO Finland
Intravenous
3.8
11.7
52
158
C41.32
ICD-10 Finland
Chondrosarcoma of the ribs, sternum and clavicle
+∞
11.5
11
*
C40.00
ICD-10 Finland
Malignant tumor of the scapula and the long bones of the upper extremity without histology
124.7
11.5
12
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
11.2
11.5
21
20
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.3
11.5
35
73
WZC30
NOMESCO Finland
Teaching
3.3
11.3
61
215
JN4CD
NOMESCO Finland
Very extensive body CT
6.0
11.3
31
57
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.5
11.0
53
172
TPX15
NOMESCO Finland
Removal of vascular injection port
62.3
10.7
12
*
C40.01
ICD-10 Finland
Osteosarcoma of the scapula and the long bones of the upper extremity
+∞
10.5
10
*
C41.40
ICD-10 Finland
Pelvic bones, sacrum and coccyx
+∞
10.5
10
*
9220/3-C40.0
ICD-O-3
Chondrosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.5
10
*
R50.9
ICD-10 Finland
Fever, unspecified
3.1
10.5
63
240
L04AX04
ATC
lenalidomide; oral
24.4
10.3
14
6
N02BE01
ATC
paracetamol; systemic, rectal
2.9
10.2
253
2036
N02AX02
ATC
tramadol; systemic, rectal
2.3
10.2
138
823
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
17.5
10.0
15
9
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
17.5
10.0
15
9
WF002
NOMESCO Finland
Radical radiotherapy
4.9
9.9
32
71
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
8.9
9.7
20
24
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
56.9
9.7
11
*
329
Kela drug reimbursment
Lenalidomide
31.2
9.5
12
*
Z51.5
ICD-10 Finland
Palliative care
4.2
9.4
36
95
C41.22
ICD-10 Finland
Chondrosarcoma of the spine
+∞
9.4
9
*
9220/3-C41.4
ICD-O-3
Chondrosarcoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
9.4
9
*
1707A
ICD-9 Finland
Malignant neoplasm of bone and articular cartilage, Long bones of lower limb[ALARAAJAN PITKIEN LUIDEN SYÖPÄ,OSTEOSARCOMA]
+∞
9.4
9
*
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
9.4
9
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.9
9.3
30
67
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.5
9.1
23
38
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
38.0
9.1
11
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
9.1
8.9
18
21
R52.0
ICD-10 Finland
Acute pain
7.6
8.9
20
28
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.7
8.7
29
67
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.3
8.7
32
82
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.6
8.6
29
68
J01MA12
ATC
levofloxacin; systemic
2.7
8.6
65
284
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
20.8
8.5
12
6
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
20.8
8.5
12
6
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
8.4
80
396
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
9.9
8.4
16
17
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
+∞
8.4
8
*
NER20
NOMESCO Finland
Incomplete excision of soft tissue tumour of pelvis
+∞
8.4
8
*
9180/3-C40.0
ICD-O-3
Osteosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
8.4
8
*
C41.41
ICD-10 Finland
Osteosarcoma of the pelvic bones, sacrum and coccyx
+∞
8.4
8
*
C41.82
ICD-10 Finland
Overall chondrosarcoma in bone and articular cartilage
+∞
8.4
8
*
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
8.4
8
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
+∞
8.4
8
*
C40.91
ICD-10 Finland
Osteosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
8.4
8
*
C40.11
ICD-10 Finland
Osteosarcoma of the short bones of the upper extremity
+∞
8.4
8
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.8
8.3
20
31
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.9
8.2
22
40
WF003
NOMESCO Finland
Adjuvant radiotherapy
6.2
8.2
21
36
L28
ICPC
Limited function/disability (L)
2.7
8.1
60
258
2392A
ICD-9 Finland
Neoplasm of unspecified nature, Bone, soft tissue and skin
34.4
8.1
10
*
WX002
NOMESCO Finland
Sedation and analgesia
2.5
8.1
71
334
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
22.8
8.1
11
5
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
9.8
7.9
15
16
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
7.8
45
166
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.8
7.8
17
23
NFB60
NOMESCO Finland
Demanding prosthetic replacement of hip
19.0
7.7
11
6
NF3AD
NOMESCO Finland
Femur CT
82.1
7.5
8
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
82.1
7.5
8
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
82.1
7.5
8
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
82.1
7.5
8
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
7.4
43
159
ZXA05
NOMESCO Finland
Left side
2.2
7.4
87
473
AA1AA
NOMESCO Finland
Head X-ray examination
9.7
7.4
14
15
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
7.3
7
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
7.3
7
*
C41.3
ICD-10 Finland
Malignant neoplasm: Ribs, sternum and clavicle
+∞
7.3
7
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
7.3
7
*
C40.10
ICD-10 Finland
Malignant tumor of the upper limb's short bones without histology
+∞
7.3
7
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
16.3
7.3
11
7
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.3
7.2
15
19
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.4
7.2
34
109
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
9.1
7.1
14
16
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
7.1
70
350
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.4
7.1
20
39
L03AA14
ATC
lipegfilgrastim; parenteral
7.8
7.0
15
20
J04AB02
ATC
rifampicin; systemic
11.3
6.9
12
11
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
6.8
59
273
GDB10
NOMESCO Finland
Wedge resection of lung
41.0
6.8
8
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.1
6.5
24
63
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
71.3
6.4
7
*
9102
FHL
Trepanation or removal of the local bone process
14.7
6.4
10
7
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
6.4
32
107
JN6AD
NOMESCO Finland
CT of torso and neck
8.4
6.4
13
16
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
8.4
6.4
13
16
ZXA00
NOMESCO Finland
Right side
2.0
6.3
88
509
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.7
6.3
20
45
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
6.3
41
164
J05AB01
ATC
aciclovir; systemic
2.2
6.3
69
361
NGB99
NOMESCO Finland
Other primary prosthetic replacement of knee joint, other or unspecified
+∞
6.3
6
*
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
6.3
6
*
GDA20
NOMESCO Finland
Excision of lesion of lung
+∞
6.3
6
*
9220/3-C41.0
ICD-O-3
Chondrosarcoma, NOS, of bones of skull and face and associated joints
+∞
6.3
6
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
6.3
6
*
NGR40
NOMESCO Finland
Extensive excision of tumor of knee or lower leg with repair
+∞
6.3
6
*
C40.23
ICD-10 Finland
Ewing's sarcoma in the long bones of the lower extremity
+∞
6.3
6
*
C40.12
ICD-10 Finland
Chondrosarcoma of the short bones of the upper extremity
+∞
6.3
6
*
C40.93
ICD-10 Finland
Malignant tumor in unspecified locations in the bones and articular cartilage of the extremities
+∞
6.3
6
*
C41.00
ICD-10 Finland
Malignant tumor of the skull or facial bone without histology
+∞
6.3
6
*
C41.09
ICD-10 Finland
Malignant tumor of the skull or facial bones other or unspecified histology
+∞
6.3
6
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
27.3
6.3
8
*
B01AB04
ATC
dalteparin; parenteral
4.2
6.2
22
55
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
6.2
95
568
NG1AD
NOMESCO Finland
Knee CT examination
6.9
6.1
14
21
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
5.0
6.0
18
38

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40760888) Immunoglobulin light chains.free panel - Serum
50
61
9.60
39.23
10.9
5.8
—
—
—
0
0
(4035726)
89
211
5.53
37.24
1.7
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
80
7.98
36.06
11.3
5.0
mg/l
37.5
148.2
0.69
46
59
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
80
7.98
36.06
11.3
5.0
mg/l
38.0
32.9
0.09
46
60
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
104
293
4.86
35.28
8.2
4.6
u/l
231.7
239.2
0.32
104
280
(21494890) Protein electrophoresis panel - 24 hour Urine
32
31
11.41
29.39
3.2
3.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
197
1046
3.47
24.44
8.9
5.2
g/l
34.4
35.8
2.70
189
979
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
24
20
12.93
24.12
1.2
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
139
604
3.38
23.94
4.6
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
164
793
3.29
23.53
4.6
2.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
66
175
4.53
23.42
8.8
3.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
200
1110
3.30
22.28
13.8
7.3
mmol/l
1.2
1.2
1.22
186
1014
(3023368) Bacteria identified in Blood by Culture
147
705
3.08
20.74
7.6
4.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
208
1215
3.21
20.56
17.5
7.8
mmol/l
1.2
1.2
1.44
176
1037
(3042936) Bacteria identified in Isolate by Culture
98
378
3.34
19.97
2.5
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
51
6.89
19.69
1.8
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
159
819
2.95
19.38
9.5
6.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
67
5.95
19.04
1.7
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
19
16
12.59
18.86
2.4
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
209
1262
3.06
18.75
10.2
6.2
e9/l
0.6
0.6
0.96
193
1099
(40768804) Tissue Pathology biopsy report
175
961
2.91
18.74
3.2
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
197
1154
2.97
18.66
6.5
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
230
1471
3.25
18.50
24.1
10.2
e9/l
3.6
4.1
2.80
213
1292
(3019198) Lymphocytes [#/volume] in Blood
211
1296
3.01
18.06
10.3
6.3
e9/l
1.6
1.9
3.28
195
1150
(3006315) Basophils [#/volume] in Blood
208
1268
2.99
18.05
10.3
6.2
e9/l
0.0
0.0
2.93
191
1106
(3013115) Eosinophils [#/volume] in Blood
211
1301
2.99
17.84
11.1
6.7
e9/l
0.2
0.2
0.23
196
1149
(3022096) Basophils/100 leukocytes in Blood
193
1138
2.87
17.70
10.3
6.5
%
0.5
0.7
2.58
188
1068
(3037756) Immunofixation for Serum or Plasma
32
58
6.04
17.35
4.5
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
196
1175
2.85
17.24
10.3
6.3
%
2.9
2.9
0.02
191
1100
(3019069) Monocytes/100 leukocytes in Blood
196
1182
2.82
16.92
10.7
6.7
%
9.0
8.6
0.95
191
1117
(3002030) Lymphocytes/100 leukocytes in Blood
197
1210
2.75
16.09
10.5
6.5
%
24.9
28.0
3.50
191
1135
(3003396) Base excess in Arterial blood by calculation
77
289
3.22
16.07
10.5
10.1
mmol/l
1.4
1.1
0.31
60
242
(3018010) Neutrophils/100 leukocytes in Blood
195
1197
2.72
15.85
10.0
6.2
%
59.2
57.1
1.48
189
1131
(3015377) Calcium [Moles/volume] in Serum or Plasma
149
807
2.64
15.56
9.4
3.6
mmol/l
2.3
2.4
0.69
139
709
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
264
1919
3.68
15.42
17.7
7.9
u/l
91.1
81.5
1.21
257
1799
(3032080) INR in Blood by Coagulation assay
173
1027
2.57
14.66
12.1
9.3
inr
1.2
1.3
0.39
47
283
(3013826) Glucose [Moles/volume] in Serum or Plasma
222
1489
2.77
14.54
9.1
5.5
mmol/l
6.5
6.7
0.98
214
1390
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
40
6.42
14.08
1.4
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
27
51
5.71
13.98
1.6
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
75
4.81
13.92
8.2
3.2
u/ml
0.3
0.3
0.20
20
38
(3021879) Hepatitis B virus core Ab [Presence] in Serum
58
203
3.29
13.43
1.3
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
75
319
2.79
12.26
1.5
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
69
282
2.87
12.15
1.9
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
72
4.51
11.82
1.6
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
30
74
4.38
11.42
1.6
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
89
429
2.51
11.22
7.1
3.2
mmol/l
2.5
2.4
0.20
83
374
(3002179) Metamyelocytes/100 leukocytes in Blood
53
195
3.08
11.20
4.8
4.3
%
0.8
0.4
0.98
24
47
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
25
7.14
11.13
2.2
3.2
%
15.3
10.5
—
8
15
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
99
3.86
11.11
6.9
2.1
g/l
7.9
7.5
0.33
23
75
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
99
3.86
11.11
6.9
2.1
g/l
3.6
3.7
0.36
20
69
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
99
3.86
11.11
6.9
2.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
128
728
2.30
11.09
9.3
4.3
ph
7.4
7.4
0.51
34
136
(3026493) Urate [Moles/volume] in Serum or Plasma
117
646
2.31
10.82
4.0
2.9
umol/l
7715.1
8390.8
0.05
107
557
(3018677) aPTT in Platelet poor plasma by Coagulation assay
87
422
2.48
10.77
5.7
2.2
s
29.6
29.4
0.18
82
412
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
85
409
2.49
10.70
2.4
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
33
6.07
10.67
1.5
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
113
623
2.29
10.42
23.9
7.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
32
89
3.90
10.39
7.2
2.5
g/l
0.6
1.1
0.41
26
77
(3011412) CD3 cells [#/volume] in Blood
19
34
5.89
10.35
2.4
2.7
e9/l
1.0
1.3
0.39
14
17
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
14
6
24.35
10.33
3.0
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
68
299
2.64
10.28
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
55
219
2.84
10.06
5.3
4.5
%
1.5
1.0
0.84
26
70
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
47
172
3.05
9.99
17.8
8.7
mmol/l
24.9
24.7
0.13
47
172
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
25
6.70
9.91
2.4
3.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
29
79
3.95
9.68
14.7
7.5
mg/l
1.3
1.5
0.92
29
72
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
90
3.72
9.47
8.1
2.2
g/l
9.0
10.3
1.20
24
78
(3023520) Reticulocytes [#/volume] in Blood
54
221
2.75
9.35
4.8
3.1
e9/l
75.7
68.0
0.93
46
172
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
78
382
2.40
9.32
1.5
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
50
201
2.78
8.94
5.5
4.7
%
0.2
0.2
0.06
23
61
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
145
930
2.06
8.73
4.4
3.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
19
40
5.00
8.71
2.7
4.4
%
2.7
1.1
0.87
19
34
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
91
3.55
8.59
7.7
2.2
g/l
3.2
3.2
0.16
20
70
(3021788) Differential panel - Synovial fluid
17
33
5.39
8.51
1.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
58
4.21
8.50
1.8
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
26
6.01
8.41
3.0
3.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
61
286
2.41
7.94
2.4
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
60
281
2.41
7.83
2.3
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
46
190
2.67
7.78
5.7
4.7
%
0.0
0.2
0.49
23
51
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
136
2.96
7.77
12.2
15.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
51
223
2.54
7.69
20.0
9.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
11
6
18.94
7.65
3.5
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
53
237
2.49
7.63
5.0
3.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
14
26
5.59
7.32
1.1
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
160
1111
1.92
7.25
20.1
9.9
e9/l
0.0
0.0
0.57
137
904
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
57
3.88
7.04
1.4
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
31
5.04
7.00
1.8
3.5
—
—
—
0
0
(3026782) Osmolality of Urine
90
521
2.03
6.89
4.8
2.8
mosm/kgh2o
580.9
585.4
0.07
84
436
(3009343) pH of Capillary blood
45
196
2.52
6.82
5.3
3.6
ph
7.5
7.4
—
5
21
(3030467) Casts [#/volume] in Urine by Automated count
115
727
1.93
6.82
3.7
3.1
e6/l
0.8
0.3
0.38
89
547
(36304419) Bacteria [Presence] in Urine
112
702
1.94
6.81
3.6
3.1
—
—
—
0
0
(44790049)
16
37
4.51
6.57
1.6
1.6
—
—
—
0
0
(44790047)
16
37
4.51
6.57
1.6
1.6
—
—
—
0
0
(44790048)
16
37
4.51
6.57
1.6
1.6
—
—
—
0
0
(44806118)
16
37
4.51
6.57
1.6
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
25
5.39
6.55
2.8
1.5
pg
30.8
32.8
0.63
13
25
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
47
4.01
6.35
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
47
4.01
6.35
1.8
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
121
794
1.86
6.30
4.4
3.2
e6/l
37.6
139.8
0.66
99
619
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
43
4.13
6.25
1.4
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
54
266
2.25
6.22
4.3
4.5
ug/l
3.9
59.4
1.09
42
218
(3013707) Erythrocyte sedimentation rate by Westergren method
228
1828
1.96
6.19
6.2
4.3
mm/h
16.5
11.8
3.04
222
1678
(3000850) Epithelial cells [#/volume] in Urine
90
546
1.92
5.91
3.5
2.6
e6/l
5.1
4.3
0.42
83
477
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
82
3.09
5.71
1.9
1.8
u/l
9.9
7.6
0.28
15
68
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
37
4.21
5.69
2.7
4.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
88
3.00
5.66
2.7
3.0
—
—
—
0
0
(3017704) Immunofixation for Urine
10
17
6.05
5.66
3.0
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
212
1685
1.83
5.61
4.4
3.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
21
5.40
5.56
1.5
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
288
2562
3.01
5.55
38.2
17.0
mmol/l
139.3
139.6
1.59
282
2500
(3023103) Potassium [Moles/volume] in Serum or Plasma
288
2566
2.98
5.46
38.7
17.1
mmol/l
3.9
4.0
2.91
281
2499
(3037467) Urinalysis macro (dipstick) panel - Urine
211
1686
1.80
5.35
5.4
4.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
35
4.14
5.22
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
31
4.33
5.14
1.3
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
31
4.33
5.14
1.3
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
45
3.70
5.12
6.1
4.5
%
60.6
57.7
0.36
16
45
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
50
3.54
5.10
1.4
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
110
739
1.76
5.08
4.9
3.5
ng/l
1232.4
1339.8
0.11
102
629
(21494814) CD8 cells/100 lymphocytes in Specimen
9
9
10.26
5.06
1.8
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
101
666
1.77
4.96
1.5
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
37
3.92
4.87
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
47
3.54
4.81
1.4
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
43
3.62
4.67
1.7
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
134
969
1.68
4.65
4.6
4.0
ng/l
27.6
46.1
1.59
112
692
(3018095) Leukocytes [#/volume] in Urine
126
897
1.69
4.64
5.5
3.7
e6/l
70.8
97.9
0.33
102
656
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
281
2510
2.41
4.63
35.3
14.4
mg/l
28.8
24.6
1.30
256
1956
(3026008) Bacteria identified in Urine by Culture
104
706
1.72
4.55
4.2
3.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
44
3.53
4.52
5.1
3.9
e9/l
3.8
4.7
0.97
15
44
(3035637) Corticotropin [Mass/volume] in Plasma
12
30
4.12
4.48
1.7
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
36
172
2.24
4.44
4.9
7.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
35
3.83
4.41
1.2
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
75
467
1.80
4.41
1.6
1.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
245
2098
1.83
4.37
39.2
17.5
%
14.1
13.7
4.88
240
2057
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
22
4.66
4.33
1.9
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
9
9.09
4.30
2.0
2.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
9
9.09
4.30
1.1
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
263
2309
1.97
4.25
29.0
13.1
ml/min/173m2
84.6
82.2
0.78
233
1890
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
33
155
2.27
4.24
2.5
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
31
142
2.32
4.22
2.2
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
184
2.15
4.15
2.4
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
43
227
2.04
4.13
2.5
2.5
g/l
0.2
0.2
0.82
43
214
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
32
3.86
4.12
1.3
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
58
3.04
4.08
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
39
200
2.09
4.04
3.0
2.5
ml/min/173m2
77.2
67.8
0.58
18
83
(40767503) Oxygen content in Capillary blood by calculation
15
49
3.17
3.86
3.6
3.0
%
15.4
16.1
—
10
25
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
15
6.14
3.84
1.9
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
155
2.19
3.83
5.4
3.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
15
50
3.10
3.74
1.5
1.4
e6/l
15656.8
7668.2
—
10
40
(3028626) Oxygen [Partial pressure] in Capillary blood
22
91
2.53
3.73
6.6
3.1
kpa
8.6
8.5
0.15
22
80
(3044941) Cell count panel - Synovial fluid
10
25
4.10
3.73
1.6
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
68
2.75
3.63
1.4
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
51
3.04
3.62
1.1
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
45
253
1.91
3.62
13.1
5.1
mmol/l
2.1
1.6
0.47
39
193
(3012544) pH of Venous blood
46
261
1.90
3.60
12.9
5.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
16
57
2.91
3.58
1.8
1.7
e6/l
124.6
194.6
0.19
16
46
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
91
631
1.63
3.55
2.2
2.1
mg/l
2.7
3.0
0.88
77
550
(21494434) Karyotype in Bone marrow
11
31
3.64
3.51
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
6
10.16
3.51
2.0
3.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
78
525
1.65
3.41
4.1
1.9
mg/l
1.3
1.4
0.16
63
402
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
7
8.71
3.27
7.0
5.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
19
4.85
3.26
1.6
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
38
3.25
3.25
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
15
5.44
3.21
1.6
1.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
44
257
1.83
3.16
13.3
5.0
kpa
6.0
5.7
0.92
44
246
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
16
5.10
3.07
1.6
1.8
—
—
—
0
0
(3019225) pH of Specimen
42
245
1.83
3.03
10.0
4.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
48
293
1.76
2.98
1.5
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
58
376
1.67
2.90
3.7
2.5
g/l
2.3
2.3
0.12
58
350
(3024354) Oxygen [Partial pressure] in Venous blood
38
218
1.85
2.89
11.1
4.5
kpa
4.2
4.6
1.13
38
207
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
18
4.53
2.81
3.6
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
23
4.00
2.79
1.1
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
79
558
1.56
2.79
9.5
5.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
19
4.29
2.69
1.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
285
2657
2.01
2.63
22.4
10.5
u/l
27.4
26.8
0.20
279
2561
(3015235) Bicarbonate [Moles/volume] in Capillary blood
17
74
2.37
2.63
2.4
2.2
mmol/l
26.9
24.5
1.38
17
63
(3016018) Differential panel - Cerebral spinal fluid
8
20
4.08
2.58
1.5
1.9
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
7
7.24
2.56
1.0
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
77
552
1.53
2.53
3.4
1.5
g/l
2.4
2.4
0.04
60
325
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
89
2.21
2.50
2.2
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
48
310
1.65
2.44
10.7
7.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
52
2.57
2.39
3.2
2.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
64
446
1.55
2.38
2.9
2.7
e6/l
1.0
0.9
0.05
37
260
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
8
6.33
2.38
1.4
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
78
2.25
2.35
1.4
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
61
422
1.56
2.34
4.0
2.9
e6/l
3.4
1.8
0.58
35
241
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
99
2.09
2.32
2.4
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
53
2.52
2.31
4.5
3.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
280
2615
1.80
2.28
28.1
13.2
—
—
—
0
0
(3020891) Body temperature
20
100
2.07
2.26
7.6
4.7
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
9
29
3.17
2.24
1.2
1.5
g/l
32.9
26.9
—
9
24
(3036481) Cortisol [Moles/volume] in Serum or Plasma
38
237
1.69
2.21
4.5
2.1
nmol/l
367.0
374.7
0.13
38
218
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
49
2.51
2.13
3.1
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
10
5.06
2.08
1.6
2.1
%
233.6
124.6
—
5
10
(3013512) EKG study
93
718
1.42
2.07
5.3
4.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
15
4.06
2.05
1.2
1.5
umol/l
13.3
11.4
—
6
15
(3023410) Appearance of Cerebral spinal fluid
8
26
3.13
2.02
1.6
2.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
77
2.14
2.00
1.8
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
17
84
2.08
1.99
2.6
1.8
iu/l
17.5
22.5
0.27
12
74
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
21
3.39
1.97
2.1
3.6
u/ml
18.6
63.0
—
7
21
(40768806) Pleura Pathology biopsy report
8
27
3.01
1.95
1.3
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
11
4.60
1.95
1.2
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
11
4.60
1.95
1.8
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
66
483
1.47
1.94
4.0
3.7
ng/l
37.5
270.4
2.24
53
386
(40768441) Liver Pathology biopsy report
6
16
3.80
1.94
1.0
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
128
1053
1.37
1.94
3.3
2.6
ug/l
417.2
136.9
0.93
122
969
(40761535) Cells panel - Urine sediment
33
207
1.67
1.89
4.6
3.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
22
3.23
1.89
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
53
0.00
1.89
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
5
12
4.22
1.83
1.2
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
142
1198
1.34
1.79
5.2
3.7
estimate
0.0
0.0
0.00
36
232
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
293
0.52
1.79
1.6
2.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
10
41
2.49
1.77
8.3
3.5
u/ml
31.5
32.5
—
10
41
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
61
2.18
1.74
1.3
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
30
2.71
1.73
1.9
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
30
2.71
1.73
1.9
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
30
2.71
1.73
1.9
1.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
120
993
1.34
1.71
2.5
2.4
nmol/l
77.0
76.8
0.03
109
877
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
115
946
1.34
1.70
6.1
3.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
18
97
1.91
1.70
4.7
4.2
g/l
0.2
0.2
—
9
42
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
12
55
2.23
1.69
1.3
1.4
—
102.9
—
0
7
(3012441) Differential panel - Pleural fluid
7
25
2.84
1.66
1.1
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
292
2797
1.90
1.66
48.8
21.0
e12/l
4.3
4.5
10.23
283
2718
(3025941) Bacteria identified in Stool by Culture
25
151
1.71
1.66
1.3
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
292
2798
1.89
1.64
48.8
21.1
e9/l
6.5
6.7
1.12
283
2719
(3027315) Oxygen [Partial pressure] in Blood
12
56
2.19
1.63
3.7
3.8
kpa
7.0
8.3
1.05
12
56
(3013290) Carbon dioxide [Partial pressure] in Blood
12
56
2.19
1.63
3.7
3.8
kpa
5.1
5.0
0.30
12
56
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
116
961
1.33
1.62
1.9
2.0
pmol/l
90.7
92.4
0.11
66
512
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
14
3.61
1.62
1.0
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
141
1204
1.32
1.59
6.8
4.9
estimate
0.0
0.0
0.00
36
230
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
318
0.57
1.58
1.5
2.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
91
730
1.35
1.57
2.8
2.2
u/l
641.6
254.9
0.47
86
699
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
78
1.97
1.57
1.1
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
5
15
3.37
1.53
1.2
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
15
79
1.94
1.52
3.5
3.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
238
0.53
1.48
1.2
1.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
28
2.53
1.46
1.6
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
291
2796
1.78
1.45
49.0
21.1
e9/l
243.6
245.1
0.13
282
2721
(40761536) Microorganisms panel - Urine sediment
31
206
1.56
1.45
6.1
3.7
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
16
3.16
1.44
1.8
1.2
mmol/l
2.2
1.8
—
5
16
(3021960) Folate [Moles/volume] in Serum or Plasma
74
583
1.35
1.43
1.6
1.5
nmol/l
20.2
20.6
0.06
67
494
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
12
60
2.04
1.40
1.3
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
34
234
1.51
1.37
2.4
2.2
nmol/l
11.0
14.2
1.58
24
214
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
17
2.97
1.36
2.4
1.7
%
92.4
97.6
—
5
17
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
47
2.17
1.35
3.0
4.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
200
1814
1.29
1.34
4.6
3.7
pmol/l
14.8
14.8
0.05
181
1620
(3024928) Oxygen saturation in Venous blood
11
54
2.08
1.34
2.8
6.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
81
656
1.32
1.30
6.3
4.1
estimate
0.0
0.0
0.00
35
223
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
20
123
1.67
1.27
5.8
4.6
%
1.2
1.3
0.06
20
123
(3009542) Hematocrit [Volume Fraction] of Blood
245
2292
1.34
1.26
34.7
15.4
%
36.7
40.2
7.19
174
1664
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
49
2.08
1.23
1.1
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
19
2.66
1.22
1.4
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
71
1.87
1.21
1.7
1.5
ug/g
251.7
287.5
—
6
40
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
26
2.33
1.19
1.3
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
26
2.33
1.19
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
1.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
26
2.33
1.19
1.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
79
1.81
1.19
1.5
1.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
33
0.00
1.17
0.0
1.1
—
8.2
—
0
20
(3009261) Glucose [Presence] in Urine by Test strip
139
1221
1.25
1.16
5.4
3.7
estimate
0.0
0.0
0.00
36
221
(3022806) Fractional oxyhemoglobin in Capillary blood
7
32
2.21
1.08
4.7
2.2
%
81.1
90.1
—
7
32
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
33
2.15
1.06
2.6
1.7
ug/l
12.1
18.5
—
7
33
(3019230) Fractional oxyhemoglobin in Venous blood
9
46
1.98
1.04
3.6
6.2
%
42.4
65.1
—
9
46
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
34
2.08
1.03
1.0
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
70
842
0.78
1.03
3.0
2.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
133
0.52
1.01
1.4
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
35
2.02
1.00
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
35
2.02
1.00
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
246
0.63
0.99
1.3
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
84
1.70
0.99
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
82
689
1.26
0.98
5.3
3.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
30
0.00
0.98
0.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
85
1.68
0.96
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
85
1.68
0.96
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
95
1.61
0.89
1.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
30
2.02
0.87
1.0
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
56
456
1.28
0.87
1.6
1.7
nmol/l
1380.0
1205.0
0.49
41
343
(3000330) Specific gravity of Urine by Test strip
19
129
1.50
0.85
3.3
3.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
137
0.57
0.85
1.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
45
1.80
0.85
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
31
1.95
0.85
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
269
1.34
0.82
1.5
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
1.4
—
0
12
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
33
1.83
0.79
2.0
2.6
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
25
0.00
0.79
0.0
1.3
—
11.0
—
0
8
(1761482) Bacteria [#/volume] in Urine by Culture
12
74
1.65
0.79
5.2
4.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
244
0.68
0.79
1.2
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
213
2248
0.83
0.77
5.9
5.9
mmol/mol
39.7
40.3
0.38
193
2093
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
55
1.66
0.74
1.7
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
25
2.02
0.73
1.6
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
40
320
1.29
0.72
1.4
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
311
1.29
0.72
4.5
4.6
%
30.5
31.6
0.27
28
198
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
142
0.62
0.71
1.8
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
236
2251
1.21
0.70
5.3
4.4
mu/l
2.0
1.9
0.57
214
2041
(3011397) Hemoglobin [Presence] in Urine by Test strip
64
545
1.22
0.69
4.7
3.8
—
—
—
0
0
(4146454)
5
27
1.87
0.68
1.4
2.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
27
1.87
0.68
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
92
0.54
0.68
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
103
1.48
0.66
3.5
2.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
62
1.63
0.66
1.5
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
13
87
1.52
0.64
4.4
3.8
mmol/l
4.0
3.9
0.26
13
79
(3051611) Lipemic interference index of Serum or Plasma
5
29
1.74
0.64
2.8
2.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
141
0.63
0.61
1.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
10.5
—
1234.5
—
0
20
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
107
966
1.17
0.60
4.2
5.1
ug/l
2.4
2.8
0.31
96
857
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
2.0
—
0
10
(3023419) Bacteria identified in Sputum by Culture
6
35
1.73
0.58
5.8
2.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
35
1.73
0.58
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
124
1.39
0.57
2.5
2.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
55
1.47
0.56
1.6
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
38
1.59
0.54
2.0
3.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
38
1.59
0.54
2.0
3.2
mmol/l
107.2
105.3
—
6
38
(3041354) Potassium [Moles/volume] in Venous blood
6
38
1.59
0.54
2.0
3.2
mmol/l
4.1
4.1
—
6
38
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
175
1648
1.14
0.53
3.5
3.2
u/l
52.9
51.0
0.10
166
1545
(3045414) Leukocytes [Presence] in Urine
13
92
1.43
0.51
1.5
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
31
373
0.81
0.47
1.1
1.3
u/ml
19.4
13.5
—
8
151
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
116
0.68
0.46
1.8
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
83
0.60
0.46
4.2
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
50
1.41
0.45
1.4
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
33
1.52
0.41
2.6
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
2.6
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
2.6
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
33
1.52
0.41
1.4
8.1
mmol/l
6.6
6.3
—
5
27
(3020874) Milk IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.2
—
0
6
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.2
—
0
5
(4094501)
8
60
1.34
0.40
1.4
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
34
1.48
0.40
2.6
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
34
1.48
0.40
2.6
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
34
1.48
0.40
2.6
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
19
151
1.28
0.39
1.4
1.3
u/ml
844.3
183.6
0.45
19
137
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
1.2
—
0
6
(3037522) Nuclear Ab [Titer] in Serum
37
318
1.19
0.39
1.1
1.3
titre
240.0
438.8
—
6
67
(4306422)
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
36
1.40
0.38
1.4
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
135
1.27
0.36
1.2
1.3
—
—
—
0
0
(4034850)
6
88
0.68
0.33
4.2
10.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
60
545
1.13
0.32
6.1
3.9
kg/l
1.0
1.0
0.26
12
74
(40768793) Breast Pathology biopsy report
7
53
1.33
0.31
1.3
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
240
2456
0.90
0.31
4.5
4.9
mmol/l
2.6
2.7
1.39
215
2255
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
185
0.80
0.30
1.7
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
119
0.75
0.28
2.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
119
0.75
0.28
2.2
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
119
0.75
0.28
3.1
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
120
0.74
0.28
2.2
1.4
—
—
—
0
0
(4010399)
14
171
0.81
0.27
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
73
0.68
0.26
1.4
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
235
2401
0.91
0.26
4.3
4.4
mmol/l
1.4
1.4
1.42
210
2202
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
28
246
1.15
0.24
2.4
2.4
u/l
44.7
32.7
0.43
20
210
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
53
489
1.10
0.22
1.6
1.8
pmol/l
409.8
449.0
0.72
41
418
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
9.5
—
0
11
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
146.4
—
0
10
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
28.3
—
0
10
(40765089) Chromosome analysis panel - Blood by G-banded
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
12
0.00
0.21
0.0
1.2
—
7.8
—
0
12
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
12
0.00
0.21
0.0
1.4
—
8.0
—
0
6
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
0.3
—
0
12
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
237
2413
0.92
0.21
4.3
4.4
mmol/l
4.4
4.6
1.80
214
2229
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
59
632
0.92
0.21
1.9
1.7
mmol/l
1.3
1.4
0.13
53
537
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
385
0.90
0.20
1.2
1.3
iu/ml
75.2
35.7
0.31
11
120
(3016879) Cocaine [Presence] in Urine
9
113
0.79
0.20
2.2
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.20
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
164
1596
1.06
0.17
3.2
3.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
88
0.79
0.14
1.7
2.0
—
—
—
0
0
(1002224) Polysomnography panel
8
99
0.80
0.14
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
69
722
0.94
0.13
3.6
3.2
mg/l
4069.2
146.7
1.30
42
480
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
94
1.18
0.13
1.5
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
83
800
1.05
0.12
3.0
3.1
mmol/l
7.3
7.7
0.36
65
673
(3028707) Methadone [Presence] in Urine by Screen method
6
57
1.05
0.08
4.2
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
61
589
1.04
0.08
1.1
1.3
u/ml
2.0
1.5
0.19
17
157
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
16
173
0.92
0.07
2.7
2.4
—
20.8
—
0
10
(3019832) Treponema pallidum Ab [Presence] in Serum
22
234
0.94
0.06
1.6
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
75
765
0.97
0.04
3.3
4.0
mg/mmol
6.0
9.5
0.71
43
502
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
290
1.04
0.03
1.4
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
32
327
0.98
0.01
3.3
2.4
ug/g
179.8
130.4
0.39
24
255
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
56
567
0.98
0.01
2.4
3.0
ug/l
0.9
0.8
0.38
40
371
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
237
2364
1.01
0.00
4.6
4.6
mmol/l
5.8
6.0
1.31
214
2149
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
231
2316
0.99
0.00
3.9
4.0
mmol/l
1.3
1.3
0.34
208
2124
(36660697) Celiac disease serology panel - Serum
20
202
0.99
0.00
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
105
0.95
0.00
1.7
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
77
774
0.99
0.00
4.0
4.4
%
22.1
21.4
0.17
37
383
(3022621) pH of Urine by Test strip
17
174
0.98
0.00
6.3
2.3
—
—
—
0
0
(3000492) Spirometry study
23
234
0.98
0.00
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
46
464
0.99
0.00
1.3
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
8
81
0.99
0.00
1.5
1.6
mu/l
227.9
314.9
—
8
76
(4015189)
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
59
0.84
0.00
2.6
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
92
0.98
0.00
1.9
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
10.4
—
24.7
—
0
7
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
12.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
23.9
—
0
6
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
18.5
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
67
0.89
0.00
1.2
1.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.0
—
3086.7
—
0
6
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
88
0.91
0.00
2.4
1.5
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
1.2
—
0
7
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_BONE_CARTILAGE – Malignant neoplasm of bone and articular cartilage

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).